Market Tracker

12/19 6:05pm ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

156.63
Data as of Dec 19
 +6.49 / +4.32%
Today’s Change
54.02
Today|||52-Week Range
497.00
+129.39%
Year-to-Date

Today’s Trading

Previous close150.14
Today’s open149.41
Day’s range148.41 - 158.18
Volume1,240,328
Average volume (3 months)566,063
Market cap$3.3B
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+48.91%
Earnings growth (this year)-282.47%
Earnings growth (next 5 years)-6.30%
Revenue growth (last year)-33.71%
P/E ratioNM
Price/Sales759.12
Price/Book36.85

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+0.13+0.41%
AVNRAvanir Pharmaceutica...-0.14-0.82%
NPSPNPS Pharmaceuticals ...-0.57-1.56%
MYGNMyriad Genetics Inc+0.85+2.39%
Data as of 3:59pm ET, 12/19/2014

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$1.73
Annual revenue (last year)$1.6M
Annual profit (last year)-$67.8M
Net profit margin-4,180.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts